Skip to main content
. 2006 Jun;72(6):4455–4460. doi: 10.1128/AEM.02095-05

TABLE 3.

Distribution of VPAI in V. parahaemolyticus MTase gene-positive and V. parahaemolyticus MTase gene-negative strains of V. parahaemolyticus

Strain Serotype V. parahaemolyticus MTase gene PCR product (683 bp) Presence of 0.9-kb PCR product obtained with VPAI-screening primersa Southern hybridization result forb:
VP0380 (probe L) V. parahaemolyticus MTase (probe M) VP0403 (probe R)
QM98284 O3:K6 +c + + +
QM115996 O3:K6 + + + +
AN-2416 O3:K6 + + + +
AO-97 O3:K6 + + + +
AP-24659 O1:K56 +
AP-19569 O5:KUT +
TW-271 K8 +
TW-288 K6 +
TW-421 K29 +
TW-491 K15 +
QM-113892 Unknown +
QM-113890 Unknown +
T8-9 Unknown +
T1-41 Unknown +
QM-112998 Unknown
AP-33593 O4:K55
TW-414 K29
TW-435 K60
T7-25 Unknown
a

VPAI-screening primers (VP0379-F and VP0404-R) located outside VPAI (Fig. 1) are expected to amplify a 0.9-kb fragment from V. parahaemolyticus strains that lack VPAI.

b

See Fig. 1 for the locations of the three VPAI hybridization probes.

c

+, gene amplimer or Southern hybridization signal present; −, gene amplimer or Southern hybridization signal absent.